Imperial’s COVID-19 vaccine

Latest news

Press Release: Imperial team join IfM Engage consortium to boost UK semiconductor sector

Press Release: Imperial team join IfM Engage consortium to boost UK semiconductor sector

Team from Imperial join IfM Engage consortium, commissioned by the Department for Science, Innovation & Technology (DSIT), for a study into infrastructure to grow the UK semiconductor industry - and a new strategic coordination function for the sector. read more

Experts issue weather warning for Britain’s electricity grid

Experts issue weather warning for Britain’s electricity grid

Britain’s ever-changing weather could put its landmark net zero climate target at risk and become a threat to the power grid’s security unless policymakers take action. Independent report for Drax Electric Insights. read more

Low carbon transport research centre launches at Imperial

Low carbon transport research centre launches at Imperial

A major research initiative focussing on the development of low emission vehicles has launched this week at Imperial College London, which will develop knowledge and expertise that could be applied through consultancy projects in the future. read more

Related case studies

Management of pests and vectors of disease

Management of pests and vectors of disease

Helping small-holder farmers with cost-effective techniques to manage pests and vectors of disease, reducing the use of chemical pesticides and promoting the efficiency of natural processes. read more

Paediatric HIV symposium – 20th International AIDS Conference

Paediatric HIV symposium – 20th International AIDS Conference

Our consultants shared their expertise in anti-retroviral drugs, HIV infections/paediatric HIV to help ViiV Healthcare deliver symposia on growing the future leaders in paediatric HIV at the International Aids Conference 2014. read more

Neuropathic pain drug development

Neuropathic pain drug development

Our consultants shared their expertise in neuropathic pain area treatments to support Spinifex’s drug discovery and development programs. read more